Endo Int’l Plc (NASDAQ:ENDP) shares traded 2.49% up during most recent session to reach at the closing price of $7.01. The stock exchanged hands 4.99 Million shares versus average trading capacity of 5.66 Million shares, yielding a market cap of $1.57 Billion. Wall Street analysts covering the stock are projecting that the stock will reach $9.08 within the next 52-weeks. The mean target projections are based on 18 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Endo Int’l Plc (NASDAQ:ENDP) high price target of $12 and with a conservative view have low price target of $6.
BMO Capital “Maintained” Endo Int’l Plc (NASDAQ:ENDP) in a research note issued to investors on 3/05/18 to Market Perform with price target of $9.
Additionally on 2/28/18 Gabelli & Co. “Downgrades” Endo Int’l Plc (NASDAQ:ENDP) to Hold setting price target at $0 and on 2/26/18 JMP Securities “Downgrades” the stock to Market Perform at $0. Furthermore on 2/23/18 Barclays “Maintained” the stock to Equal-Weight at $10.
On the other hand the company has Relative Strength Index (RSI 14) of 50.6 along with Average True Range (ATR 14) of 0.36, Consequently Endo Int’l Plc (NASDAQ:ENDP)’s weekly and monthly volatility is 3.49%, 5.40% respectively. The company’s beta value is at 0.35.
In terms of Buy, Sell or Hold recommendations, Endo Int’l Plc (NASDAQ:ENDP) has analysts’ mean recommendation of 2.7. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Endo Int’l Plc (NASDAQ:ENDP)’s minimum EPS for the current quarter is at $0.48 and can go high up to $0.61. The consensus mean EPS for the current quarter is at $0.54 derived from a total of 19 estimates from the analysts who have weighed in on projected earnings. However the company reported $1.23 earnings per share for the same quarter during last year.
Previously Endo Int’l Plc (NASDAQ:ENDP) reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.61 by $0.16. The company posted an earnings surprise of 26.2%.
Endo Int’l Plc (NASDAQ:ENDP)’s revenue estimates for the current quarter are $688.42 Million according to 16 number of analysts, for the current quarter the company has high revenue estimates of $727.4 Million in contradiction of low revenue estimates of $647.61 Million. For the current year the company’s revenue estimates are $2.74 Billion compared to low analyst estimates of $2.66 Billion and high estimates of $2.8 Billion according to 19 number of analysts.
Currently Endo Int’l Plc (NASDAQ:ENDP)’s shares owned by insiders are 0.3%, whereas shares owned by institutional owners are 98.3%. However the six-month change in the insider ownership was recorded -1.33%, as well as three-month change in the institutional ownership was recorded 3.03%.
Endo Int’l Plc (NASDAQ:ENDP) 52-week high price stands at $14.15 and low price stands at $5.77, its price distance from 52-week high is -50.46% while its distance from 52-week low price is 21.49%. The stock hit its 52-week high on 06/08/17, and 52-week low on 10/27/17.
Endo Int’l Plc (NASDAQ:ENDP)’s trailing twelve month revenues are $3.47 Billion, whereas its price to sales ratio for the same period is 0.45. Its book value per share for the most recent quarter is $2.17 while its price to book ratio for the same period is 3.23, as for as the company’s cash per share for the most recent quarter is $0, however its price to cash per share ratio for the same period is 0. The stock has 5 year expected PEG ratio of 0 whereas its trailing twelve month P/E ratio is 0.